NXEN logo

Nexien BioPharma, Inc. Stock Price

OTCPK:NXEN Community·US$7.1k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

NXEN Share Price Performance

US$0.0001
-0.02 (-99.38%)
US$0.0001
-0.02 (-99.38%)
Price US$0.0001

NXEN Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk with weak fundamentals.

6 Risks
1 Reward

Nexien BioPharma, Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$188.1k

Other Expenses

-US$188.1k

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
-0.0027
0%
0%
-83.3%
View Full Analysis

About NXEN

Founded
n/a
Employees
n/a
CEO
Richard Greenberg
WebsiteView website
www.nexienbiopharma.com

Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions in the United States. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.

Recent NXEN News & Updates

Recent updates

No updates